SCHEMBL953501

SCHEMBL953501

C=COC(=O)CCCCCCCCCCCCCCCCCCC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.67
DGKA P23743 1/20 0.55
LMNA P02545 2/20 0.52
PAM P19021 2/20 0.50
MAPT P10636 2/20 0.48
MAPK1 P28482 1/20 0.48
CES2 O00748 3/20 0.48
CES1 P23141 3/20 0.48
FAAH O00519 1/20 0.47
PPARG P37231 5/20 0.46
PPARD Q03181 5/20 0.46
PPARA Q07869 5/20 0.46
HDAC11 Q96DB2 4/20 0.46
GPR84 Q9NQS5 3/20 0.46
ALDH1A1 P00352 2/20 0.46
TLR2 O60603 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
FABP4 P15090 2/20 0.46
PTPN1 P18031 2/20 0.46
SLC22A6 Q4U2R8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20476 1.00 TSHR (0.67) TSHRDGKALMNAPAMMAPT
SCHEMBL3503427 1.00 TSHR (0.67) TSHRDGKALMNAPAMMAPT
SCHEMBL10543145 1.00 TSHR (0.67) TSHRDGKALMNAPAMMAPT
SCHEMBL18055 1.00 TSHR (0.67) TSHRDGKALMNAPAMMAPT
SCHEMBL346985 1.00 TSHR (0.67) TSHRDGKALMNAPAMMAPT
SCHEMBL7762583 1.00 TSHR (0.67) TSHRDGKALMNAPAMMAPT
SCHEMBL680310 1.00 TSHR (0.67) TSHRDGKALMNAPAMMAPT
SCHEMBL7540354 1.00 TSHR (0.67) TSHRDGKALMNAPAMMAPT
SCHEMBL14344225 1.00 TSHR (0.67) TSHRDGKALMNAPAMMAPT
SCHEMBL3503239 1.00 TSHR (0.67) TSHRDGKALMNAPAMMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 116 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113151373-B Preparation method and application of sucrose monoester with antibacterial and antitumor activities 武汉臻治生物科技有限公司 2023-07-04 CN claimed
US-20180222878-A1 COMPOSITION FOR INHIBITING FORMATION OF SNARE COMPLEX, CONTAINING MYRICETIN DERIVATIVES Research & Business Foundation Sungkyunkwan University (KR) 2018-08-09 US claimed
EP-3329913-A1 COMPOSITION FOR INHIBITING FORMATION OF SNARE COMPLEX, CONTAINING MYRICETIN DERIVATIVES Research & Business Foundation Sungkyunkwan University (KR) 2018-06-06 EP claimed
EP-1453999-A4 CELLULOSE-BASED END-GRAIN CORE MATERIALS AND COMPOSITES RYAN DALE B (US) 2005-06-08 EP claimed
US-20050048273-A1 Reinforced composites and system and method for making same CORLYTE PRODUCTS, LLC 2005-03-03 US claimed
WO-2005010082-A2 REINFORCED COMPOSITES AND SYSTEM AND METHOD FOR MAKING SAME CORLYTE PRODUCTS, LLC (US) 2005-02-03 WO claimed
EP-1453999-A1 METHOD AND SYSTEM FOR INTEGRATION OF SOFTWARE APPLICATIONS Ryan, Dale B. (US) 2004-09-08 EP claimed
US-20030207098-A1 Load-carrying structures comprising bamboo fibers and polymers RYAN DALE BRADLEY (US) 2003-11-06 US claimed
US-6576331-B1 Load-carrying structures comprising bamboo fibers and polymers VANTEM COMPOSITE TECHNOLOGIES, LLC 2003-06-10 US claimed
WO-2003040451-A1 CELLULOSE-BASED END-GRAIN CORE MATERIAL AND COMPOSITES RYAN DALE B (US) 2003-05-15 WO claimed
US-20030049428-A1 Cellulose-based end-grain core material and composites CORLYTE PRODUCTS LLC 2003-03-13 US claimed
WO-2000051796-A1 LOAD-CARRYING STRUCTURES COMPRISING BAMBOO FIBERS AND POLYMERS RYAN DALE B (US) 2000-09-08 WO claimed
US-5980672-A Linear bamboo fiber core for filament winding applications VANTEM COMPOSITE TECHNOLOGIES, LLC 1999-11-09 US claimed
US-5876649-A Process of making a load-carrying structure VANTEM COMPOSITE TECHNOLOGIES, LLC 1999-03-02 US claimed
WO-1998010906-A1 LINEAR BAMBOO FIBER CORE FOR FILAMENT WINDING APPLICATIONS RYAN DALE B (US) 1998-03-19 WO claimed
US-20250134851-A1 ALTERNATIVE NOVEL MATERIAL TO BOTULINUM NEUROTOXIN AND PREPARATION METHOD THEREOF ACTIVON CO., LTD. (KR) 2025-05-01 US disclosed
EP-4403163-A1 ALTERNATIVE NOVEL MATERIAL TO BOTULINUM NEUROTOXIN AND PREPARATION METHOD THEREFOR Intron Biotechnology, Inc. (KR) 2024-07-24 EP disclosed
US-5876649-A Process of making a load-carrying structure VANTEM COMPOSITE TECHNOLOGIES, LLC 1999-03-02 US disclosed
WO-1998010906-A1 LINEAR BAMBOO FIBER CORE FOR FILAMENT WINDING APPLICATIONS RYAN DALE B (US) 1998-03-19 WO disclosed
CN-1141445-A Toner for two-component magnetic developing agent YAMATA INDUSTRY CO LTD (JP) 1997-01-29 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250134851-A1 ALTERNATIVE NOVEL MATERIAL TO BOTULINUM NEUROTOXIN AND PREPARATION METHOD THEREOF SNAP29, VAMP7, ACHE TSHR 3942/4885DGKA 2923/4885LMNA 632/4885
US-20180222878-A1 COMPOSITION FOR INHIBITING FORMATION OF SNARE COMPLEX, CONTAINING MYRICETIN DERIVATIVES VAMP7, FLOT1, SNAP29 TSHR 4756/4885DGKA 4329/4885LMNA 507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.